Hydreight Technologies Inc. has announced a strategic partnership with Perfect Scripts LLC, a Texas-based company. Under the binding letter of intent, Hydreight will acquire an initial 5% equity stake in Perfect Scripts, with an option to increase this to 40%. The partnership aims to establish a 503B pharmacy in the United States, ensuring Hydreight access to the lowest pricing for products from Perfect Scripts. This collaboration is expected to enhance Hydreight's control over pharmaceutical production, distribution, and pricing, particularly for key medications, and strengthen its position in the U.S. healthcare market. The partnership is anticipated to provide increased margins, a secure supply chain, and greater vertical integration for Hydreight, supporting its mission to improve access to modern healthcare.